FIELD: medicine, ophthalmology, pharmacy. SUBSTANCE: eye drops have carnosine ($$$-alanyl-L-histidine), concentrated hydrochloric acid and water at the following ratio of components: carnosine 1.0-5.0 g; concentrated hydrochloric acid up to pH = 6.5-7.2, and water up to 100 ml. Eye drops were used for treatment of posttraumatic and age cataracts and inflammatory eye diseases. EFFECT: enhanced effectiveness of treatment. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CATARACT TREATMENT AND EYE DROPS FOR IMPLEMENTATION THEREOF | 2016 |
|
RU2662364C2 |
| METHOD OF CONSERVATIVE TREATMENT AND PREVENTION OF NUCLEAR TYPE OF AGE CATARACT | 2009 |
|
RU2411926C2 |
| NEW EYE DROPLETS FOR CONSERVATIVE TREATMENT AND PREVENTION OF THE AGE-RELATED NUCLEAR CATARACT | 2015 |
|
RU2637875C2 |
| METHOD OF CONSERVATIVE TREATMENT AND PREVENTION OF CORTICAL TYPE OF AGE CATARACT | 2009 |
|
RU2418568C2 |
| THERAPY OF EARLY CATARACT | 2008 |
|
RU2367387C1 |
| EYE DROPS | 2009 |
|
RU2404768C1 |
| METHOD OF TREATING EXPERIMENTAL CHEMICAL BURNS AND CATARACTS MODELED ON CHINCHILLAS RABBITS | 2019 |
|
RU2711543C1 |
| METHOD OF TREATING BEGINNING AGE CATARACT | 2011 |
|
RU2460502C1 |
| PSEUDODIPEPTIDES, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT | 1994 |
|
RU2166510C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTIVE MAINTENANCE OF DEVELOPMENT AND TREATMENT OF INITIAL STAGE OF AGE CATARACT (VERSIONS) | 2007 |
|
RU2352352C1 |
